alpha-aminopyridine has been researched along with Dementia, Vascular in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Z; Gao, Y; Guo, L; He, X; Huang, L; Huang, YY; Li, Z; Liang, J; Liang, SH; Luo, HB; Wu, D; Wu, R; Yu, S; Zhou, Q | 1 |
| Dabertrand, F; Fontaine, JT; Joutel, A; Rosehart, AC | 1 |
2 other study(ies) available for alpha-aminopyridine and Dementia, Vascular
| Article | Year |
|---|---|
Discovery and Optimization of α-Mangostin Derivatives as Novel PDE4 Inhibitors for the Treatment of Vascular Dementia.
Topics: Aminopyridines; Animals; Benzamides; Cyclic Nucleotide Phosphodiesterases, Type 4; Cyclopropanes; Dementia, Vascular; Dogs; Drug Design; Humans; Male; Mice, Inbred C57BL; Molecular Structure; Phosphodiesterase 4 Inhibitors; Protein Binding; Rolipram; Structure-Activity Relationship; Vomiting; Xanthones | 2020 |
HB-EGF depolarizes hippocampal arterioles to restore myogenic tone in a genetic model of small vessel disease.
Topics: Aminopyridines; Animals; Arterioles; Cerebral Small Vessel Diseases; Dementia, Vascular; Heparin-binding EGF-like Growth Factor; Hippocampus; Membrane Potentials; Membrane Transport Modulators; Mice; Microcirculation; Models, Genetic; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Potassium Channels, Voltage-Gated; Vasoconstriction | 2020 |